{"nctId":"NCT00276484","briefTitle":"To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)","startDateStruct":{"date":"2006-02"},"conditions":["Hypercholesterolemia"],"count":579,"armGroups":[{"label":"1","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: atorvastatin"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: atorvastatin","Drug: ezetimibe"]}],"interventions":[{"name":"atorvastatin","otherNames":[]},{"name":"atorvastatin","otherNames":[]},{"name":"ezetimibe","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient with LDL-C \\>70 mg/dL \\& on a stable dose of atorvastatin 40 mg\n\nExclusion Criteria:\n\n* Pregnant or lactating women or intending to become pregnant\n* Patient with sensitivity or intolerance to ezetimibe or atorvastatin","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"79 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change From Baseline to Week 6 in Low-Density Lipoprotein (LDL)-C","description":"Percent Change in LDL-C = \\[(week 6 value - baseline value)/baseline value\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-27.4","spread":null},{"groupId":"OG001","value":"-11.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in High-Density Lipoprotein Cholesterol (HDL-C)","description":"Percent Change in HDL-C = \\[(week 6 value - baseline value)/baseline value\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":null},{"groupId":"OG001","value":"-1.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in Non-High-Density Lipoprotein Cholesterol (Non-HDL-C)","description":"Percent Change in Non-HDL-C = \\[(week 6 value - baseline value)/baseline value\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-23.3","spread":null},{"groupId":"OG001","value":"-9.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in Total-Cholesterol","description":"Percent Change in Total-C = \\[(week 6 value - baseline value)/baseline value\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.9","spread":null},{"groupId":"OG001","value":"-6.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in Triglycerides (TG)","description":"Percent Change in TG = \\[(week 6 value - baseline value)/baseline value\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.3","spread":null},{"groupId":"OG001","value":"-5.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in Apolipoprotein B (Apo B)","description":"Percent Change in Apo B = \\[(week 6 value - baseline value)/baseline value\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.8","spread":null},{"groupId":"OG001","value":"-7.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in Apolipoprotein A-I (Apo A-I)","description":"Percent Change in Apo A-I = \\[(week 6 value - baseline value)/baseline value\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","spread":null},{"groupId":"OG001","value":"-1.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in Total-Cholesterol (TC):High-Density Lipoprotein Cholesterol (HDL-C) Ratio","description":"Percent Change in TC:HDL-C Ratio = \\[(week 6 ratio - baseline ratio)/baseline ratio\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.0","spread":null},{"groupId":"OG001","value":"-5.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in Low-Density Lipoprotein-Cholesterol:High-Density Lipoprotein-Cholesterol (LDL-C:HDL-C) Ratio","description":"Percent Change in LDL-C:HDL-C Ratio = \\[(week 6 ratio - baseline ratio)/baseline ratio\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-26.4","spread":null},{"groupId":"OG001","value":"-9.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in Apolipoprotein B:Apolipoprotein A-I (Apo B:Apo A-I) Ratio","description":"Percent Change in Apo B:Apo A-I Ratio = \\[(week 6 ratio - baseline ratio)/baseline ratio\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.9","spread":null},{"groupId":"OG001","value":"-5.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in Non-High-Density Lipoprotein-Cholesterol:High-Density Lipoprotein-Cholesterol (Non-HDL-C:HDL-C) Ratio","description":"Percent Change in non-HDL-C:HDL-C Ratio = \\[(week 6 ratio - baseline ratio)/baseline ratio\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-22.2","spread":null},{"groupId":"OG001","value":"-7.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline to Week 6 in C Reactive Protein (CRP)","description":"Percent Change in CRP = \\[(week 6 value - baseline value)/baseline value\\]\\*100%","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-18.3","spread":null},{"groupId":"OG001","value":"-11.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients Who Attained Target Low-Density Lipoprotein Cholesterol (LDL-C) <70 mg/dL at Week 6","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"204","spread":null},{"groupId":"OG001","value":"88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73","spread":null},{"groupId":"OG001","value":"191","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9},"commonTop":["Upper respiratory tract infection","Pain in extremity","Diarrhoea","Myalgia","Headache"]}}}